Physician profile
Bradley Ryan
NPI 1467475053
$3,047.63
in general payments reported to CMS, 2019-2025
12 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.14 · 2020: $64.53 · 2021: $1,804 · 2022: $100 · 2023: $748 · 2024: $66.60 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $720 · Food and Beverage: $237 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $720.08 |
| Food and Beverage | $236.75 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,371.37 | 2021-2023 | Da Vinci Surgical System |
| Teleflex LLC | $157.95 | 2024-2025 | Quikclot, Deknatel |
| Takeda Pharmaceuticals U.S.A., INC. | $124.83 | 2020-2023 | Gattex |
| Davol INC. | $99.25 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Ethicon US, LLC | $43.64 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $40.84 | 2019-2024 | |
| Acell, INC. | $35.36 | 2019 | |
| Integra Lifesciences Corporation | $34.69 | 2021 | |
| Kerecis Limited | $28.81 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medtronic, INC. | $21.87 | 2021 | |
| Tela Bio, INC. | $20.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.